APA (7th ed.) Citation

X, Z., J, M., C, R., MJ, S., M, B., S, K., . . . JM, W. (2026). Real-world efficacy and tolerability of ixazomib-based combination therapies in advanced multiple myeloma and other plasma cell neoplasms. Therapeutic advances in hematology, 17, 20406207261421841. https://doi.org/10.1177/20406207261421841

Chicago Style (17th ed.) Citation

X, Zhou, et al. "Real-world Efficacy and Tolerability of Ixazomib-based Combination Therapies in Advanced Multiple Myeloma and Other Plasma Cell Neoplasms." Therapeutic Advances in Hematology 17 (2026): 20406207261421841. https://doi.org/10.1177/20406207261421841.

MLA (9th ed.) Citation

X, Zhou, et al. "Real-world Efficacy and Tolerability of Ixazomib-based Combination Therapies in Advanced Multiple Myeloma and Other Plasma Cell Neoplasms." Therapeutic Advances in Hematology, vol. 17, 2026, p. 20406207261421841, https://doi.org/10.1177/20406207261421841.